Serological Response of Horses and Laboratory Animals to Equine Influenza Vaccines

2015 ◽  
pp. 503-509 ◽  
Author(s):  
G. N. Frerichs ◽  
R. Burrows ◽  
Coral C. Frerichs
1994 ◽  
Vol 112 (2) ◽  
pp. 421-437 ◽  
Author(s):  
J. A. Mumford ◽  
H. Wilson ◽  
D. Hannant ◽  
D. M. Jessett

SUMMARYEquine influenza vaccines containing inactivated whole virus and Carbomer adjuvant stimulated higher levels and longer lasting antibody to haemagglutinin in ponies than vaccines of equivalent antigenic content containing aluminium phosphate adjuvants. Five months after the third dose of vaccine containing Carbomer adjuvant, ponies were protected against clinical disease induced by an aerosol of virulent influenza virus (A/equine/Newmarket/79, H3N8). In contrast ponies which received vaccine containing aluminium phosphate adjuvant were susceptible to infection and disease. There was an inverse correlation between prechallenge levels of antibody detected by single radial haemolysis (SRH) and duration of virus excretion, pyrexia and coughing. All ponies with antibody levels equivalent to SRH zones of ≥ 154 mm2 were protected against infection and all those with levels ≤ 85 mm2 were protected from disease.


2016 ◽  
Vol 39 ◽  
pp. S75-S76
Author(s):  
C.A. Caldevilla ◽  
Y. L. Paredes Rojas ◽  
L.I. Ibañez ◽  
N. Mattion

2021 ◽  
Vol 37 ◽  
pp. 00015
Author(s):  
V Ivanov ◽  
V Bezgin ◽  
O Shvets

An associated inactivated vaccine has been developed for the specific prophylaxis of tetanus and equine influenza caused by various influenza viruses of the H3N8 serotype. The strain composition of the associated vaccine was determined considering the recommendations of the International Epizootic Bureau, as well as the virus circulating in Russia, isolated in 2007 and therefore posing a certain danger to horse breeding in the Russian Federation. The immunogenic properties of the new associated vaccine were studied in a laboratory model and horses. The results of studies of the associated vaccine FFE Kurskaya Biofabrika showed that the investigated vaccine preparation has high immunogenic activity and can cause a long-term intense immune response against influenza and tetanus in laboratory animals and horses.


1983 ◽  
Vol 11 (2) ◽  
pp. 133-136 ◽  
Author(s):  
J.M. Wood ◽  
G.C. Schild ◽  
C. Folkers ◽  
Jennifer Mumford ◽  
R.W. Newman

Sign in / Sign up

Export Citation Format

Share Document